Barshes Neal R, Lee Timothy C, Balkrishnan Rajesh, Karpen Saul J, Carter Beth A, Goss John A
Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX 77030, USA.
Transplantation. 2006 Jan 27;81(2):195-201. doi: 10.1097/01.tp.0000188149.90975.63.
Orthotopic liver transplantation (OLT) is an effective treatment for fulminant hepatic failure (FHF), but postOLT mortality is higher for patients with FHF than for patients with other indications for OLT. In the current study, a large cohort of patients who underwent OLT for FHF was evaluated to develop and validate a system useful for estimating postOLT patient survival.
The 1,457 patients who underwent OLT for FHF in the United States between 1988 and 2003 were enrolled through the UNOS database. This group was divided into a modeling group (n=972) and a crossvalidation group (n=486). With a multivariate regression analysis, the modeling group was used to identify clinical parameters that had a significant association with postOLT survival. This regression analysis was used to create a scoring system that was subsequently assessed in the crossvalidation group.
Four risk factors were identified with the multivariate analysis: 1) body mass index > or = 30 kg/m2; 2) serum creatinine > 2.0 mg/dL; 3) recipient age > 50 years old; and 4) history of life support. By assigning points based on the number of risk factors present, the scoring system was able to differentiate between low-risk patients (5-year survival, 81%) and high-risk patients (5-year survival, 42%). The relative risk of postOLT mortality increased by approximately 150% for each additional point.
The scoring system risk-stratified the crossvalidation group and accurately predicted postOLT survival. A scoring system utilizing clinical and demographic information readily available prior to OLT may help predict the probability of survival after OLT for FHF.
原位肝移植(OLT)是治疗暴发性肝衰竭(FHF)的有效方法,但FHF患者OLT后的死亡率高于其他OLT适应证患者。在本研究中,对一大群因FHF接受OLT的患者进行了评估,以开发和验证一个有助于估计OLT后患者生存率的系统。
通过器官共享联合网络(UNOS)数据库纳入了1988年至2003年间在美国因FHF接受OLT的1457例患者。该组患者被分为建模组(n = 972)和交叉验证组(n = 486)。通过多变量回归分析,建模组用于确定与OLT后生存有显著关联的临床参数。该回归分析用于创建一个评分系统,随后在交叉验证组中进行评估。
多变量分析确定了四个风险因素:1)体重指数≥30kg/m²;2)血清肌酐>2.0mg/dL;3)受者年龄>50岁;4)生命支持史。通过根据存在的风险因素数量分配分数,该评分系统能够区分低风险患者(5年生存率,81%)和高风险患者(5年生存率,42%)。每增加一分,OLT后死亡的相对风险增加约150%。
该评分系统对交叉验证组进行了风险分层,并准确预测了OLT后生存情况。利用OLT前易于获得的临床和人口统计学信息的评分系统可能有助于预测FHF患者OLT后的生存概率。